Marshall Wace, LLP Mannkind Corp Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Mannkind Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 91,306 shares of MNKD stock, worth $391,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,306
Previous 926,683
90.15%
Holding current value
$391,702
Previous $5.96 Million
92.3%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$96.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$74.3 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$40.6 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$37.5 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$33.4 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.1B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...